Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Atul Pande files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew J. Fromkin - $7.96M of IMVT open-market activity in the last 12 months
- Jay S. Stout - $2.24M of IMVT open-market activity in the last 12 months
- Melanie Gloria - $1.60M of IMVT open-market activity in the last 12 months
- Tiago Girao - $1.41M of IMVT open-market activity in the last 12 months
- Tuyl Christopher van - $1.02M of IMVT open-market activity in the last 12 months
- Eric Venker - $462K of IMVT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Atul Pande?
Atul Pande is a corporate insider, tracked as Director of Immunovant, Inc. (IMVT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Atul Pande submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Atul Pande been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($646K) across all tracked filings.
Where can I see all of Atul Pande's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Atul Pande and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
